UK Medical Cannabis Strains Guide: All You Need to Know

What These Terms Actually Mean

In UK medical cannabis, strain classification based on botanical origin provides a useful framework, though modern understanding is more nuanced. The traditional taxonomy refers to plant morphology and geographic origin rather than definitive pharmacological differences.

Indica strains originate from Hindu Kush mountains and surrounding regions. These plants are typically shorter, bushier, with broad leaves and shorter flowering cycles (7-9 weeks). Historically associated with relaxing, body-focused effects, though cannabinoid and terpene profiles matter more than classification alone.

Sativa strains come from equatorial regions and are taller, with narrow leaves and longer flowering times (10-16 weeks). Traditionally linked to uplifting, cerebral effects, though again, this depends heavily on chemotype rather than simple species designation.

Hybrid strains combine indica and sativa genetics, offering varied effects depending on the specific cross and which parent strain is more dominant. These represent the majority of modern medical cannabis available in UK pharmacies.

Why Classification Matters Less Than You Think

Recent cannabis science demonstrates that the specific cannabinoid ratios and terpene profiles are far more important than whether a strain is classified as indica or sativa. Two strains both labelled “indica” can have completely different therapeutic effects based on their unique chemistry. Modern UK prescribers increasingly focus on:

• THC:CBD ratio and absolute concentrations
• Dominant and minor terpenes
• Minor cannabinoids (CBG, CBC, THCV)
• Individual patient response and trial outcomes

The THC:CBD ratio fundamentally determines therapeutic application and psychoactivity. Understanding these ratios is essential for matching products to your specific condition.

Absolute Concentrations Matter

A 1:1 ratio at 5mg THC: 5mg CBD per dose differs substantially from 15mg THC: 15mg CBD. Higher absolute concentrations provide greater therapeutic effect but also increase potential side effects. UK prescribers typically start patients with lower absolute doses regardless of ratio, then titrate upward based on response.

Individual Variation in Response

Genetic factors, including CYP3A4 enzyme expression and endocannabinoid system variability, mean patients respond differently to identical ratios. What works perfectly for one patient may be ineffective or poorly tolerated by another. This is why trial and adjustment with your prescriber is essential.

Terpenes are aromatic compounds that give cannabis its flavour and aroma, but they also significantly influence pharmacological effects through the “entourage effect.” These plant compounds interact with cannabinoids and your endocannabinoid system to modulate overall effects.

Reading Terpene Profiles

Most UK medical cannabis products provide detailed terpene analysis. You’ll see percentages listed; typically the top 3-5 terpenes are most abundant. A strain with 0.5% myrcene and 0.3% limonene has myrcene as the dominant terpene, suggesting more relaxing properties. Terpene percentages of 0.1% or less represent trace amounts with minimal effect.

Entourage Effect

Terpenes work synergistically with cannabinoids. A high-THC strain with dominant sedating terpenes (myrcene, linalool) will feel substantially different from one with identical THC content but energising terpenes (limonene, pinene). This is why full-spectrum products (containing all plant compounds) often perform better therapeutically than isolated cannabinoids.

The following represents strains commonly available through UK private prescription channels. Availability varies by prescriber and pharmacy. These are listed by therapeutic category:

For Chronic Pain Management

For Sleep and Insomnia

For Anxiety and PTSD

For Focus and Daytime Use